The company said Tuesday that medical technology company Olympus has shut down some of its information technology systems as part of its investigation into a possible cyberattack.
Olympus in online notification said the company over the weekend discovered “suspicious activity” on its IT systems in the Americas, including Canada, Latin America and the United States.
Olympus did not disclose details of the suspicious behavior, but said the company has dispatched a team of forensic experts to investigate possible cyberattacks. As part of efforts to contain the problem, Olympus has suspended the affected IT systems in Canada, Latin America and the United States and notified “relevant external partners,” but did not specify which of these partners.
“We are currently working as a matter of priority to resolve this issue,” the notice says. “The current results of our investigation indicate that the incident occurred in the Americas and the impact on other regions is unknown.”
Olympus did not disclose whether customer or company data was affected as a result of the incident.
The announcement follows a cyber attack that Olympus reported last month.
In early September, Olympus was attacked by malware that compromised parts of the company’s retail and manufacturing networks in Europe, the Middle East and Africa. At the time, Olympus said it had suspended access to the affected areas. As of September 14 Olympus said he found no evidence that the data had been hijacked or used by hackers.
Olympus did not immediately respond to a query as to whether the two cybersecurity incidents were related.
According to the report, the September cyberattack was linked to the BlackMatter ransomware group. TechCrunchwho considered a ransom note allegedly left on infected computers at Olympus.
The Biden administration and Congress have highlighted the need to address the growing problem of ransomware as hackers increasingly target US hospitals, government offices and schools.
Olympus, a Japanese company that makes endoscopes, microscopes and other medical and biological instruments, reported revenue of $ 1.7 billion (191.5 billion yen). for the last fiscal quarter, which ended in June – 40.2% more than a year earlier. Olympus’ operating income was $ 243 million (Y27.6 billion), an increase of 644.5%.